Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04101851
What this trial is testing

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Who this might be right for
Breast Cancer FemaleBreast Cancer
Toralf Reimer, MD PhD 350
Not applicableUnknownNCT06285058
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

Who this might be right for
Deep Learning ModelPathological Complete ResponseNon-small Cell Lung Cancer+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06276868
What this trial is testing

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 71
Testing effectiveness (Phase 2)Study completedNCT04435197
What this trial is testing

Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Ruijin Hospital 143
Testing effectiveness (Phase 2)Study completedNCT00458523
What this trial is testing

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission

Who this might be right for
Leukemia
Leeds Cancer Centre at St. James's University Hospital 54
Large-scale testing (Phase 3)WithdrawnNCT05474690
What this trial is testing

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital
Large-scale testing (Phase 3)Study completedNCT01535391
What this trial is testing

Nilotinib in PH+, BCR-, ABL+ CML Patients

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 109
Large-scale testing (Phase 3)UnknownNCT03011060
What this trial is testing

Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasm Female
The First Hospital of Jilin University 1,588
Not applicableStudy completedNCT03694613
What this trial is testing

Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants

Who this might be right for
Preterm InfantEarly-Onset Neonatal SepsisUmbilical Cord
The University of Texas Medical Branch, Galveston 65
Not applicableNot Yet RecruitingNCT06889402
What this trial is testing

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Who this might be right for
Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Large-scale testing (Phase 3)Ended earlyNCT04934670
What this trial is testing

Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 12
Large-scale testing (Phase 3)Study completedNCT06728982
What this trial is testing

Impact Of Metformin In Rectal Cancer Patients

Who this might be right for
Rectal Cancer Patients
Minia University 85
Not applicableStudy completedNCT02233374
What this trial is testing

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET

Who this might be right for
Rectal Neoplasms
Royal North Shore Hospital 27
Not applicableLooking for participantsNCT02306096
What this trial is testing

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

Who this might be right for
Breast Neoplasms
Lund University 20,000
Not applicableLooking for participantsNCT07166185
What this trial is testing

Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer

Who this might be right for
Non Metastatic HER2 Positive Breast Cancer
Blida 1 University 70
Not applicableStudy completedNCT01934452
What this trial is testing

Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients

Who this might be right for
Complete Remission in Renal Cell Carcinoma
Pfizer 77
Not applicableStudy completedNCT03238885
What this trial is testing

Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics

Who this might be right for
Locally Advanced Rectal Cancer
Sun Ying-Shi 538
Testing effectiveness (Phase 2)Looking for participantsNCT06718244
What this trial is testing

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1

Who this might be right for
Acute Lymphoblastic Leukemia
Ruijin Hospital 20
Not applicableLooking for participantsNCT06111807
What this trial is testing

Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC

Who this might be right for
Lung Cancer Stage III
University Medical Center Groningen 248
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Next Page